Supplemental data 4 -N=784 SVM model information output from R.
SVM model

FitSummary
Call:
svm(formula = form, data = xy, type = type, kernel = tolower("Radial"), gamma = gamma, cost = cost, probability = prob, fitted = TRUE, epsilon = epsilon, nu = nu, coef0 = coef0, degree = degree, scale = TRUE) ,5,8,11,14,17,20,23,26,29-decaoxo-3,9,15,18,24-pentakis(propan-2-yl 
1.88 log CFU reduction at 100 mg/kg in BALB/c mice dosed orally for 4 weeks daily 
2.17 log CFU reduction at 100 mg/kg in BALB/c mice dosed orally for 4 weeks daily
0.81 log CFU reduction at 100 mg/kg in BALB/c mice dosed orally for 4 weeks daily a Compound names in bold-faced type correspond to molecules that were also present in the consensus approach that utilized the TAACF-CB2 dual event Bayesian + the Full t 1/2 MLM Bayesian (i.e., they are part of the consensus of both consensus approaches; see Table S3 ).
b Full t 1/2 MLM Bayesian scores highlighted in green correspond to compounds that had a Bayesian score >0 for both this Bayesian and also the Pruned t 1/2 MLM Bayesian (which used all 9 descriptors). Thus, according to the published histogram-based strategy, these compounds have a higher probability of being stable than the ones listed below them. 
